Revenue (Quarterly) Chart

Historical Revenue (Quarterly) Data

View and export this data back to 2007. Start Trial.
Date Value
July 31, 2026 2.746M
April 30, 2026 3.002M
January 31, 2026 2.997M
October 31, 2025 2.972M
July 31, 2025 2.300M
April 30, 2025 1.932M
January 31, 2025 1.921M
October 31, 2024 1.962M
July 31, 2024 1.806M
April 30, 2024 4.760M
January 31, 2024 4.599M
October 31, 2023 4.532M
July 31, 2023 4.262M
April 30, 2023 4.149M
January 31, 2023 3.835M
October 31, 2022 3.896M
July 31, 2022 3.644M
April 30, 2022 4.135M
January 31, 2022 3.801M
October 31, 2021 3.756M
July 31, 2021 3.732M
April 30, 2021 3.874M
January 31, 2021 3.509M
October 31, 2020 3.595M
July 31, 2020 2.754M
Date Value
April 30, 2020 3.009M
January 31, 2020 3.065M
October 31, 2019 2.389M
July 31, 2019 2.045M
April 30, 2019 1.983M
January 31, 2019 2.025M
October 31, 2018 2.086M
July 31, 2018 2.203M
April 30, 2018 1.420M
January 31, 2018 1.362M
October 31, 2017 1.053M
July 31, 2017 0.4474M
April 30, 2017 0.4468M
January 31, 2017 0.3833M
June 30, 2016
March 31, 2016
December 31, 2015 0.00
September 30, 2015 0.00
June 30, 2015 0.00
March 31, 2015 0.00
December 31, 2014 0.00
September 30, 2014 0.00
June 30, 2014 0.00
March 31, 2014 0.00
December 31, 2013 0.00

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Quarterly) Range, Past 5 Years

View Revenue (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Quarterly) Benchmarks

View Revenue (Quarterly) Benchmarks
Start Trial
Repligen Corp. 204.13M
Bio-Techne Corp. 321.19M
BioLife Solutions, Inc. 28.47M
Maravai Lifesciences Holdings, Inc. 51.44M
MaxCyte, Inc. 7.271M